MSCs, genetically modified to express cytokines, were reported to alter the immunosuppressive microenvironment in GBM models, as observed after intratumoral administration of MSCs co‐expressing high levels of IL‐12 and IL‐7 in mouse GBM, which reduced tumor growth and induced a broad tumor‐specific immune response.177. The gene discussed is IL7; the disease is neoplasm.